|
NUP85 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.99760216648792E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64446234407478E-12 |
| Normal-vs-Stage2 |
5.93609999999245E-05 |
| Normal-vs-Stage3 |
1.8899299999986E-05 |
| Normal-vs-Stage4 |
2.424400E-02 |
| Stage1-vs-Stage2 |
6.882000E-01 |
| Stage1-vs-Stage3 |
3.502200E-01 |
| Stage1-vs-Stage4 |
9.902200E-01 |
| Stage2-vs-Stage3 |
3.593600E-01 |
| Stage2-vs-Stage4 |
8.341400E-01 |
| Stage3-vs-Stage4 |
6.558400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62736490949555E-12 |
| Normal-vs-AfricanAmerican |
5.21750420645617E-11 |
| Normal-vs-Asian |
5.162200E-02 |
| Caucasian-vs-AfricanAmerican |
8.447800E-01 |
| Caucasian-vs-Asian |
8.892000E-01 |
| AfricanAmerican-vs-Asian |
8.519400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99520433297585E-15 |
| Normal-vs-Female |
6.28386231937839E-14 |
| Male-vs-Female |
3.867200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.92799999696203E-08 |
| Normal-vs-Extreme_Weight |
2.4168445023065E-12 |
| Normal-vs-Obese |
4.61799487538883E-11 |
| Normal-vs-Extreme_Obese |
1.928430E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.754400E-01 |
| Normal_Weight-vs-Obese |
9.460200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.375400E-01 |
| Extreme_Weight-vs-Obese |
8.030200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.852200E-01 |
| Obese-vs-Extreme_Obese |
3.505800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11850528838886E-11 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.95654603629691E-12 |
| Normal-vs-Age(81-100Yrs) |
6.864200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.798600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.336000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.104300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.910100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.933940E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.091990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.52699999997641E-06 |
| Normal-VS-KIRP CIMP |
4.20210000000587E-05 |
| Normal-VS-Unclassified PRCC |
2.11010000028544E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.7478000026201E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.127800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.031800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.207600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.404140E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.747600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.16179998954635E-09 |
| Normal-vs-N1 |
1.799170E-04 |
| Normal-vs-N2 |
2.243200E-01 |
| N0-vs-N1 |
4.797200E-01 |
| N0-vs-N2 |
8.195600E-01 |
| N1-vs-N2 |
9.888200E-01 |
|
|
